Leicester Precision Medicine Institute leads discussion on innovation in healthcare at Venturefest 2017

Posted by es328 at Mar 14, 2017 04:45 PM |
University of Leicester Centre of Excellence to showcase need for collaboration between NHS and universities

Issued by the University of Leicester Press Office on 14 March 2017

The University of Leicester will be showcasing its strengths in healthcare, space and transport innovation at a major event designed to support regional innovation led growth.

Dr Alasdair Gaw, Commercial Director of Leicester Precision Medicine Institute, will lead a session on innovation in healthcare at this year’s Venturefest East Midlands at Derby Arena on 22 March.

Dr Gaw will share the stage with a senior figure from pharmaceutical giant Johnson & Johnson as he delivers his session on ‘Delivering innovation in Healthcare: The need for collaboration between industry, universities and the NHS for UK health and wealth’.

The University of Leicester, which is one of the main regional sponsors of the event, will also be showcasing its strengths in healthcare, space and transport innovation in the exhibition hall.

Dr Gaw will follow Dr Mirren Mandalia, Senior Director of New Ventures (Medical Devices) at Johnson & Johnson, on the main stage.

Innovate UK is the headline sponsor of Venturefest East Midlands, designed to showcase and support regional innovation led growth. The theme for this year is SMART Innovation which aims to show how businesses can use technology to grow and become more efficient. The talks will be followed by a Q&A session.

Anjuu Trevedi, Head of Regional Business Engagement at the University of Leicester, said: “We are really excited to be leading the healthcare session at Venturefest East Midlands this year. It enables us to showcase our medicine and healthcare expertise through the Leicester Precision Medicine Institute and to engage with forward-thinking companies and entrepreneurs interested in collaborating with the University to capitalise on the high tech, innovation-led opportunities in the healthcare sector.

“For entrepreneurs and growing businesses these sessions provide a fantastic opportunity to make connections with leaders in the field, discover new routes to market and access specialist expertise, facilities and funding to develop and implement innovative plans for their own business.”

As a Centre of Excellence at the University of Leicester, the Leicester Precision Medicine Institute is a joint venture between the University and the University Hospitals of Leicester (UHL) NHS Trust. By working with academic and industrial partners, its aim is to support and accelerate the translation of Leicester’s medical expertise in precision medicine to provide innovative therapies for patients.

For example, exhaled breath contains volatile organic compounds (VOCs) that reflect biological processes occurring within the lung and, via the vena cava, more distant organs. The East Midlands Breathomics Pathology Node (EMBER) through the University will deliver near-patient and remote sensing technologies to analyse patient breath to develop novel methods to diagnose a range of clinical conditions e.g. respiratory infections, cancers, respiratory disease such as asthma and chronic obstructive pulmonary disease and cardiovascular disorders such as heart failure.

Precision medicine is based on understanding how different people respond to medicines and treatments based on their individual characteristics (e.g. ethnicity, gender) allowing for a more personalised treatment - the right therapy, for the right patient, in the right amount, at the right time.

Dr Alasdair Gaw will lead his session, ‘Delivering innovation in Healthcare: The need for collaboration between industry, universities and the NHS for UK health and wealth’, at 12pm on Wednesday 22 March 2017.

Ends

Notes to editors:

For more information contact Anjuu Trevedi, Head of Regional Business Engagement at the University of Leicester on 0116 252 3354 or at220@le.ac.uk

Share this page: